DIAMEDICA THERAPEUTICS INC (DMAC)
CA25253X2077 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 4.54M | 4.73M | 4.71M | 7.41M | 3.88M | |||
| Marketable Securities | 48.35M | 28.77M | 40.41M | 20.10M | 4.00M | |||
| Receivables | 369.00K | 80.00K | 130.00K | 340.00K | 820.00K | |||
| Other Current Assets | 411.00K | 250.00K | 190.00K | 70.00K | 140.00K | |||
| Total Current Assets | 53.67M | 33.84M | 45.44M | 27.92M | 8.84M | |||
| Non-Current Assets | ||||||||
| PPE Net | 485.00K | 560.00K | 110.00K | 170.00K | 220.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 485.00K | 560.00K | 110.00K | 180.00K | 210.00K | |||
| TOTAL ASSETS | 54.16M | 34.40M | 45.55M | 28.10M | 9.05M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 3.00K | 10.00K | 0.00 | 10.00K | 10.00K | |||
| Accrued Expenses | 1.86M | 1.43M | 1.01M | 920.00K | 1.13M | |||
| Accounts Payable | 926.00K | 730.00K | 510.00K | 1.10M | 180.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 2.79M | 2.17M | 1.52M | 2.03M | 1.32M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.00K | 0.00 | 0.00 | 10.00K | 10.00K | |||
| Other Non-Current Liabilities | 316.00K | 400.00K | 0.00 | 50.00K | 110.00K | |||
| Total Non-Current Liabilities | 317.00K | 400.00K | 10.00K | 50.00K | 120.00K | |||
| TOTAL LIABILITIES | 3.10M | 2.57M | 1.53M | 2.08M | 1.44M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -115.56M | -96.18M | -82.50M | -68.91M | -56.62M | |||
| Additional Paid In Capital | 166.61M | 128.08M | 126.58M | 94.93M | 64.23M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 6.00K | -70.00K | -50.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 37.96M | 26.44M | 26.44M | 18.75M | 12.01M | |||
| Tangible Book Value per Share | 1.35 | 1.20 | 1.66 | 1.39 | 0.63 | |||
| Total Shareholders' Equity | 51.06M | 31.83M | 44.02M | 26.01M | 7.62M | |||
| TOTAL LIABILITIES AND EQUITY | 54.16M | 34.40M | 45.55M | 28.10M | 9.05M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | N/A | N/A | 0.00 | 0.00 | |||
| Current Ratio | 19.27 | 15.59 | 29.89 | 13.75 | 6.70 | |||
| Return On Assets (ROA) | -35.78% | -39.77% | -29.84% | -43.74% | -117.68% | |||
| Return On Equity (ROE) | -37.96% | -42.98% | -30.87% | -47.25% | -139.76% | |||
All data in USD